Caribou Biosciences, Inc.CRBUNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-1.3%
5Y CAGR+21.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-1.3%/yr
Annual compound
5Y CAGR
+21.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$36.60M-21.2%
2024$46.46M+20.8%
2023$38.46M+1.2%
2022$38.02M+62.9%
2021$23.34M+66.0%
2020$14.06M-14.6%
2019$16.46M-